Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Sartorius Stedim Biotech provides innovative bioprocess solutions for the biopharmaceutical industry. The company specializes in single-use technologies, filtration, and cell culture to optimize drug development and production.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Sartorius Stedim Biotech is scheduled to report its next quarterly earnings on 10/22/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Sartorius Stedim Biotech last reported quarterly earnings on 7/23/2026 (Q2 2026). Earnings per share (EPS) came in at 1.25 EUR.
Across its last 4 earnings reports, Sartorius Stedim Biotech stock moved by ±8.6% on average the following day. The largest reaction was -14.2% on 04/23/2026; 3 of 4 reactions were positive.
Sartorius Stedim Biotech has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.